DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Thrombocytopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Thrombocytopenia (107)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 107   Next >>

Possible Cytarabine side effects in male

Reported by a physician from France on 2012-08-07

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Anaemia, Febrile Bone Marrow Aplasia, Erythema, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: 1330 milligram
    Start date: 2012-04-18
    End date: 2012-04-24

Ccnu
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-04-18

Idarubicin HCL
    Start date: 2012-04-18
    End date: 2012-04-22

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-28

Cytarabine
    Start date: 2012-04-18
    End date: 2012-04-24

Other drugs received by patient: Bisoprolol Fumarate; Rocephin; Amikacin



Possible Cytarabine side effects in 66 year old male

Reported by a physician from France on 2012-08-07

Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Treanda
    Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-27
    End date: 2012-02-28

Melphalan Hydrochloride
    Dosage: 250 mg total dose
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-03-03

Cytarabine
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-28
    End date: 2012-03-02

Etoposide
    Dosage: 400 mg/m2 daily; uid/qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-28
    End date: 2012-03-02

Treanda
    Indication: non-Hodgkin's Lymphoma



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-08-02

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Neutropenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10

Clofarabine
    Dosage: 19 mg, qd; day 1 to 5; cycles i and ii
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Cytarabine
    Dosage: 1900 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin; Voriconazole



Possible Cytarabine side effects in

Reported by a physician from France on 2012-08-02

Patient:

Reactions: Haematuria, Febrile Bone Marrow Aplasia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 19.7 mg, qd
    Indication: Myelodysplastic Syndrome
    Start date: 2011-02-09
    End date: 2011-02-22

MK-0683
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-02-09
    End date: 2011-02-22

Other drugs received by patient: Paroxetine HCL; Prednisone TAB; Potassium Chloride; Tenoretic



Possible Cytarabine side effects in

Reported by a physician from France on 2012-08-01

Patient:

Reactions: Hyperthermia, Embolism, Anaemia, General Physical Health Deterioration, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vorinostat-Mycosis Fungoides
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-02-15
    End date: 2011-02-28

Vorinostat-Mycosis Fungoides
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2011-03-21
    End date: 2011-04-03

Cytarabine
    Dosage: 18.4 mg, qd
    Start date: 2011-02-15
    End date: 2011-02-28

Cytarabine
    Dosage: 36.8 mg, qd
    Start date: 2011-03-21
    End date: 2011-04-06

Other drugs received by patient: Plavix; Preterax (Indapamide (+) Perindopril Erbumine); Vfend; Omeprazole



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30

Patient: male

Reactions: Confusional State, Pulmonary Hypertension, Febrile Infection, Pyrexia, Mixed Liver Injury, Multi-Organ Failure, Enterovesical Fistula, Bone Marrow Failure, Pneumothorax, Acute Respiratory Distress Syndrome, Thrombocytopenia, Metabolic Acidosis, Haemoptysis, Intestinal Obstruction, Appendicitis, Lung Disorder, Renal Impairment, Zygomycosis, Respiratory Acidosis, Oliguria, Aspergillosis, Sinus Tachycardia, Septic Shock, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 10 mg
    Administration route: Oral
    Start date: 2008-03-19

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2008-03-13
    End date: 2008-03-15

Afinitor
    Dosage: 10 mg
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2008-03-13

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2008-03-13
    End date: 2008-03-19

Other drugs received by patient: Vancomycin



Possible Cytarabine side effects in male

Reported by a physician from France on 2012-07-27

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Anaemia, Febrile Bone Marrow Aplasia, Thrombocytopenia, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-28

Vidaza
    Dosage: 1330 milligram
    Start date: 2012-04-18
    End date: 2012-04-24

Cytarabine
    Start date: 2012-04-18
    End date: 2012-04-24

Ccnu
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-04-18

Idarubicin HCL
    Start date: 2012-04-18
    End date: 2012-04-22

Other drugs received by patient: Bisoprolol Fumarate; Amikacin; Rocephin



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-07-27

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1900 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Clofarabine
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10

Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B



Possible Cytarabine side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient: 46 year old female

Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Idarubicin HCL
    Dosage: 12 mg/m2, unk
    Indication: Myelodysplastic Syndrome

Carmustine
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Suberoylanilide Hydroxamic Acid
    Dosage: 500 mg, tid
    Administration route: Oral
    Indication: Myelodysplastic Syndrome

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Oncovin
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Radiotherapy



Possible Cytarabine side effects in female

Reported by a pharmacist from Italy on 2012-07-25

Patient: female

Reactions: Intestinal Ischaemia, NO Therapeutic Response, Thrombocytopenia, Haematotoxicity

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: dose reduced
    Start date: 2012-03-01

Vidaza
    Start date: 2012-01-01

Vidaza
    Dosage: 100 milligram
    Start date: 2012-02-10
    End date: 2012-02-15

Cytarabine
    Start date: 2012-01-01
    End date: 2012-02-01

Other drugs received by patient: Norvasc; Tenoretic



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-07-23

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1900 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10

Clofarabine
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-07-17

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Pneumonia, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-11

Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10
    End date: 2012-05-12

Cytarabine
    Dosage: 3800 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-12

Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis, Laryngospasm

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, on days 1-7
    Indication: Acute Myeloid Leukaemia

Idarubicin Hydrochloride
    Dosage: 12 mg/m2, on days 1-3
    Indication: Acute Myeloid Leukaemia

Mitoxantrone Hydrochloride
    Dosage: 10 mg/m2, on days 1-5
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2, on days 1-5
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in male

Reported by a physician from France on 2012-07-12

Patient: male, weighing 61.5 kg (135.3 pounds)

Reactions: Haemorrhagic Stroke, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: 3650 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-11

Cerubidine
    Dosage: 110 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-09

Afinitor
    Dosage: 70 mg, unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-05-28

Other drugs received by patient: Ondansetron; Emend; Glucose



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Idarubicin HCL
    Dosage: 12 mg/m2 on d1-3; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 100 mg/m2 on d1-7; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Mitoxantrone
    Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Vercyte



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Idarubicin HCL
    Dosage: 12 mg/m2 on d1-3; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Mitoxantrone
    Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 100 mg/m2 on d1-7; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Vercyte



Possible Cytarabine side effects in female

Reported by a pharmacist from Italy on 2012-07-06

Patient: female

Reactions: Intestinal Ischaemia, NO Therapeutic Response, Thrombocytopenia, Haematotoxicity

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: dose reduced
    Start date: 2012-03-01

Vidaza
    Start date: 2012-01-01

Cytarabine
    Start date: 2012-01-01
    End date: 2012-02-01

Vidaza
    Dosage: 100 milligram
    Start date: 2012-02-10
    End date: 2012-02-15

Other drugs received by patient: Tenoretic; Norvasc



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Pancytopenia, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Death, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Immune Globulin NOS
    Indication: Pancytopenia

Mitoxantrone
    Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: 12 mg/m2 on d1-3; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 100 mg/m2 on d1-7; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Vercyte



Possible Cytarabine side effects in male

Reported by a physician from France on 2012-07-02

Patient: male, weighing 61.5 kg (135.3 pounds)

Reactions: Haemorrhagic Stroke, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cerubidine
    Dosage: 110 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-09

Cytarabine
    Dosage: 3650 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-11

Afinitor
    Dosage: 70 mg, unk
    Administration route: Oral
    Start date: 2012-05-22
    End date: 2012-05-28

Other drugs received by patient: Ondansetron; Emend; Glucose



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02

Patient:

Reactions: Thrombocytosis, NO Therapeutic Response, Febrile Neutropenia, Bone Marrow Failure, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cytarabine
    Dosage: 10 mg/m2, in 1 cyclical
    Indication: Myeloid Leukaemia

Cytarabine
    Dosage: 10 mg/m2, in 1 cyclical
    Indication: Myelodysplastic Syndrome

Decitabine
    Dosage: 15 mg/m2, in 1 cyclical, intravenous
    Indication: Myeloid Leukaemia

Aclarubicin (Aclarubicin) Unspecified
    Dosage: 10 mg, in 1 cyclical
    Indication: Myeloid Leukaemia

Aclarubicin (Aclarubicin) Unspecified
    Dosage: 10 mg, in 1 cyclical
    Indication: Myelodysplastic Syndrome

Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
    Indication: Myelodysplastic Syndrome

Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
    Indication: Myeloid Leukaemia

Other drugs received by patient: Hydroxyurea; Homoharringtonine (Homoharringtonine)



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-29

Patient: 50 year old female

Reactions: Mouth Haemorrhage, Haemoptysis, Acute Myeloid Leukaemia, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Mitoxantrone
    Dosage: 10 mg/m2, unk
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 100 mg/m2, on days 1 to 7
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: 12 mg/m2, on days 1 and 3
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2 on days 1-5
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-27

Patient:

Reactions: Blood Bilirubin Increased, Vomiting, Nausea, Anaemia, Rash, Fatigue, Aspartate Aminotransferase Increased, Adverse Event, Neutropenia, Rash Maculo-Papular, Thrombocytopenia, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral

Revlimid
    Dosage: 10mg-25mg
    Administration route: Oral

Revlimid
    Dosage: 50 milligram
    Administration route: Oral

Revlimid
    Dosage: 10mg-25mg
    Administration route: Oral

Cytarabine
    Dosage: 1.5 milligram/sq. meter

Cytarabine
    Dosage: 10 milligram



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from Italy on 2012-06-18

Patient: male

Reactions: Epstein-Barr Virus Infection, Diarrhoea, Anaemia, Sepsis, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Vincristine Sulfate
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Doxorubicin Hydrochloride
    Indication: Burkitt's Lymphoma



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-06-14

Patient: male

Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection

Drug(s) suspected as cause:
Carmustine
    Indication: Burkitt's Lymphoma

Carboplatin
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Melphalan Hydrochloride
    Indication: Burkitt's Lymphoma

Radiotherapy
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Granulocyte Colony Stimulating Factor
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Unknown Medication
    Dosage: antimicrobial prophylaxis
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-06-11

Patient: male

Reactions: Pruritus, Renal Failure, Anaemia, Hypocalcaemia, Erythema, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mabthera
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cisplatin
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cytarabine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Other drugs received by patient: Tenormin; Dexamethasone Sodium Phosphate; Lasix; Navoban; Ramipril; Trimeton; Levothyroxine Sodium; Aspirin



Possible Cytarabine side effects in 69 year old male

Reported by a physician from Italy on 2012-06-07

Patient: 69 year old male

Reactions: Pruritus, Renal Failure, Anaemia, Hypocalcaemia, Thrombocytopenia, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 200 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cytarabine
    Dosage: 4000 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Mabthera
    Dosage: 700 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Other drugs received by patient: Levothyroxine Sodium; Ramipril; Lasix; Tenormin; Trimeton; Navoban; Aspirin; Dexamethasone Sodium Phosphate



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05

Patient: male, weighing 102.6 kg (225.7 pounds)

Reactions: Cardio-Respiratory Arrest, Respiratory Failure, Anaemia, Troponin I Increased, Thrombocytopenia, Infection

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 1600 mg, cyclic
    End date: 2011-07-28

Adriamycin PFS
    Dosage: 101 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-05

Rituximab
    Dosage: 750 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Methotrexate
    Dosage: 400 mg, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-27

Cytarabine
    Dosage: 6 g, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-30

Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: 20 unk, unk
    Administration route: Oral
    End date: 2011-07-15

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-12

Velcade
    Dosage: 2.6 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Cyclophosphamide
    Dosage: 603 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-02
    End date: 2011-07-04

Other drugs received by patient: Filgrastim; Ferrous Sulfate TAB; Heparin; Senokot; Triamcinolone Acetonide; Compazine; Ciprofloxacin; Fluconazole; Omeprazole; Mesna; Prevident; Valtrex; Vitamin C / 00008001 /; Methylprednisolone; Periogard; Ultram; Vitamin D



Possible Cytarabine side effects in 38 year old female

Reported by a physician from United States on 2012-06-01

Patient: 38 year old female

Reactions: Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Mesna
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Dasatinib
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13



Possible Cytarabine side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 52 year old male

Reactions: Haemoptysis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome Transformation, Local Swelling, Hypokalaemia, Pneumonia Cytomegaloviral, Pulmonary Haemorrhage, Zygomycosis, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clofarabine

Idarubicin HCL

Idarubicin HCL
    Dosage: 6 milligram/sq. meter
    Indication: Myelodysplastic Syndrome

Cytarabine

Vidaza
    Indication: Myelodysplastic Syndrome

Cytarabine
    Dosage: 6 g/m2
    Indication: Myelodysplastic Syndrome

Vidaza

Clofarabine
    Dosage: 22.5 milligram/sq. meter
    Indication: Myelodysplastic Syndrome

Other drugs received by patient: Fluconazole; Ciprofloxacin; Acyclovir; Metformin HCL; Insulin



Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-05-24

Patient: male, weighing 103.3 kg (227.3 pounds)

Reactions: Rectal Haemorrhage, Anaemia, Blood Blister, Petechiae, Headache, Haemolysis, Dysgeusia, Ecchymosis, Thrombocytopenia, Papule

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mercaptopurine
    Dosage: 3900 mg

Cytarabine
    Dosage: 2890 mg

Cyclophosphamide
    Dosage: 4600 mg

Methotrexate
    Dosage: 60 mg

PEG-L-Asparaginase (K-H)
    Dosage: 5700 unit

Vincristine Sulfate
    Dosage: 4 mg



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014